The Effect of Different Food Products on Post Prandial Blood Glucose in Pregnant Woman With Diabetes
NCT ID: NCT02154997
Last Updated: 2016-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2014-11-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Amongst pregnant women with Diabetes the glucose balance is extremely important during pregnancy. Glucose balance is a result of correct nutrition and an exact amount of insulin. This delicate balance requires from the pregnant women an ability to perform correct carbohydrate count.
Hyperglycemia has already been proven to affect the fetus and the neonatal outcomes. Hypoglycemia may also have a negative effect but the main danger is immediate harm to the mother and therefore to the fetus. For those reasons glucose balance is crucial and demands delicate synchronization of nutrition and insulin therapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carbohydrate Counting and DASH Intervention and Pregnancy Outcomes Among Women With Gestational Diabetes
NCT03244579
Carbohydrate Restriction in Pregnant Women With Gestation Diabetes Mellitus
NCT04051359
Meal Composition and the Influence on Pre-prandial Blood Glucose Values
NCT03028506
Effect of a Continuous Glucose Monitoring on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus
NCT02838147
Follow up Glucose Levels Among Infants of Diabetic Mothers
NCT00337142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 1 and Type 2 Diabetes
pregnant women which have a known condition of type 1 or type 2 diabetes
No interventions assigned to this group
Gestational diabetes
pregnant women which have developed Gestational diabetes
No interventions assigned to this group
Control group
Pregnant women whom do not suffer from any altered glucose metabolism
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* women who suffer from type 1 diabetes, type 2 diabetes or gestational diabetes
* Do not suffer from any intestinal disease
* Accept to sign a consent form
Exclusion Criteria
* under age of 18
* suffer from any intestinal disease
* do not accept to sign a consent form
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uri Elchalal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Uri Elchalal
Associate Professor Obstetrics and Gynecology Dept
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ram Weiss, Md PhD
Role: PRINCIPAL_INVESTIGATOR
Hebrew Universtity
Karen J Hershkop, PhD
Role: PRINCIPAL_INVESTIGATOR
Hebrew University
Limor Marko, MSc
Role: PRINCIPAL_INVESTIGATOR
Hebrew University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah Ein Kerem
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMO-0071-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.